ATE269083T1 - Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose - Google Patents

Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose

Info

Publication number
ATE269083T1
ATE269083T1 AT01908522T AT01908522T ATE269083T1 AT E269083 T1 ATE269083 T1 AT E269083T1 AT 01908522 T AT01908522 T AT 01908522T AT 01908522 T AT01908522 T AT 01908522T AT E269083 T1 ATE269083 T1 AT E269083T1
Authority
AT
Austria
Prior art keywords
group
lower alkyl
iodine
treatment
multiple sclerosis
Prior art date
Application number
AT01908522T
Other languages
English (en)
Inventor
Lennart Moeller
Jan Bergman
Original Assignee
Oxypharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxypharma Ab filed Critical Oxypharma Ab
Application granted granted Critical
Publication of ATE269083T1 publication Critical patent/ATE269083T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01908522T 2000-02-18 2001-02-16 Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose ATE269083T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel
PCT/SE2001/000326 WO2001060371A1 (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug

Publications (1)

Publication Number Publication Date
ATE269083T1 true ATE269083T1 (de) 2004-07-15

Family

ID=20278504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01908522T ATE269083T1 (de) 2000-02-18 2001-02-16 Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose

Country Status (14)

Country Link
EP (1) EP1261344B1 (de)
JP (1) JP2003522792A (de)
CN (1) CN1192777C (de)
AT (1) ATE269083T1 (de)
AU (2) AU3626601A (de)
CA (1) CA2400236C (de)
DE (1) DE60103857T2 (de)
ES (1) ES2222981T3 (de)
HU (1) HUP0204547A3 (de)
NO (1) NO323783B1 (de)
RU (1) RU2266117C2 (de)
SE (1) SE516067C2 (de)
WO (1) WO2001060371A1 (de)
ZA (1) ZA200206733B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE527639C2 (sv) * 2004-06-17 2006-05-02 Oxypharma Ab Alkylsubstituerade indolokinoxaliner
ATE473977T1 (de) 2008-04-30 2010-07-15 Univ Duisburg Essen Indolä2,3-bü-, indenä1,2-bü- und indenä2,1- büpyridoä2,3-fü quinoxalin-3-carboxylsäuren und ester, verfahren zu ihrer herstellung und ihre verwendung als antivirus- und antitumormittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600260D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Substituerade indolokinoxaliner

Also Published As

Publication number Publication date
DE60103857T2 (de) 2005-07-14
CA2400236A1 (en) 2001-08-23
ZA200206733B (en) 2003-08-22
RU2266117C2 (ru) 2005-12-20
DE60103857D1 (de) 2004-07-22
EP1261344A1 (de) 2002-12-04
AU3626601A (en) 2001-08-27
HUP0204547A2 (hu) 2003-04-28
CN1404393A (zh) 2003-03-19
HUP0204547A3 (en) 2006-01-30
CA2400236C (en) 2009-09-22
RU2002124771A (ru) 2004-03-10
NO323783B1 (no) 2007-07-09
ES2222981T3 (es) 2005-02-16
EP1261344B1 (de) 2004-06-16
AU2001236266B2 (en) 2005-03-17
WO2001060371A1 (en) 2001-08-23
SE516067C2 (sv) 2001-11-12
SE0000537L (sv) 2001-08-19
JP2003522792A (ja) 2003-07-29
NO20023892L (no) 2002-08-16
SE0000537D0 (sv) 2000-02-18
NO20023892D0 (no) 2002-08-16
CN1192777C (zh) 2005-03-16

Similar Documents

Publication Publication Date Title
NZ506574A (en) Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
EA200000842A1 (ru) Бицикло [2.2.1] гептаны и родственные соединения
HUP0002112A2 (hu) Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
HUP9904703A2 (hu) Aminotiofén-karbonsav-amidok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
NZ518144A (en) Piperazine Compounds
MY138145A (en) Thienopyrimidinediones and their use in the modulation of autoimmune disease
TW325473B (en) Azoamine derivative having methylene or substituted methylene on the amino ring
SE8600260D0 (sv) Substituerade indolokinoxaliner
EA200400223A1 (ru) Новые производные 2h-пиридазин-3-она, фармацевтические композиции, содержащие эти производные, и способ получения активного ингредиента
HUT44999A (en) Fungicide compositions containing acrylic acid derivatives as active components and process for producing the active components
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
ATE455765T1 (de) Aryloxy- und arylthioxyacetophenon-verbindungen zur behandlung von krebs
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
ATE269083T1 (de) Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
TW259785B (en) Chemical compounds
BG102658A (en) Derivatives of condensed 2,3-benzodiazepines and their use as ampa-receptor inhibitors
ES2103131T3 (es) Nuevos agentes de nucleosido carbociclico utiles como inhibidores selectivos de citoquinas proinflamatorias.
DE60010665D1 (de) Mittel zur verwendung in der transplantation
MY141374A (en) Water soluble camptothecin derivatives
GB9812211D0 (en) Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
MXPA04002838A (es) Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
HUP9700558A2 (hu) Mikrobicid készítmények

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties